Bliss Independence Test for Synergy with β-catenin inhibitor ADV.
收藏数据链接：
官方服务：
资源简介：
Bliss Independence Test for Synergy with β-catenin inhibitor ADV.
应用场景：
创建时间：
2022-03-07
相关数据集
Table S1 - Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells
CI values generated by isobologram analyses. The combination index (CI) isobologram method was used to analyze synergism for the combined drug effects. Synergy analyses were performing using CompuSyn
NIAID Data Ecosystem80
DNMT and EZH2 inhibitors synergize for gene activation in hepatocellular carcinoma cells [methylation array]. DNMT and EZH2 inhibitors synergize for gene activation in hepatocellular carcinoma cells [methylation array]
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy with cases increasing dramatically in the USA. Developing more effective targeted therapies for HCC is an urgent need. The FD
NIAID Data Ecosystem50
DataSheet_1_In vitro anti-Leishmania activity of triclabendazole and its synergic effect with amphotericin B.docx
IntroductionLeishmaniasis is a neglected tropical disease, with approximately 1 million new cases and 30,000 deaths reported every year worldwide. Given the lack of adequate medication for treating le
NIAID Data Ecosystem40
Drug-drug synergy results from titration experiments
The Library of Integrated Network-based Cellular Signatures (LINCS) is a multi-institutional, collaborative project initiated by the National Institutes of Health whose goal is to identify and categor
NIAID Data Ecosystem80
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
The persistence of latently infected cells in patients under combinatory antiretroviral therapy (cART) is a major hurdle to HIV-1 eradication. Strategies to purge these reservoirs are needed and activ
NIAID Data Ecosystem50
